Literature DB >> 25736784

MiRNAs in primary cutaneous lymphomas.

Xin Yu1, Zheng Li, Jie Liu.   

Abstract

Primary cutaneous lymphomas (PCL) compose a heterogeneous disease with still unknown aetiology and mechanisms of development. MicroRNAs (miRNAs) have recently been discovered as one of the crucial players in PCL carcinogenesis through post-transcriptional regulation of gene expression. miRNAs have been reported to be frequently deregulated in PCLs and their biological significance has been further confirmed in multiple functional experiments. Such studies help us understand molecular pathogenesis of PCL. In this review, we summarize expression of miRNAs and their corresponding roles in different subtypes of PCL. With expression and functional role of miRNAs revealed, investigation of their possible clinical use as biomarkers for diagnosis, prediction of prognosis and target for therapies, will be a promising area in the future.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736784      PMCID: PMC6496498          DOI: 10.1111/cpr.12179

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  47 in total

Review 1.  The Myc/Max/Mad network and the transcriptional control of cell behavior.

Authors:  C Grandori; S M Cowley; L P James; R N Eisenman
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 2.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

3.  Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.

Authors:  Katharina L Kopp; Ulrik Ralfkiaer; Boye S Nielsen; Robert Gniadecki; Anders Woetmann; Niels Ødum; Elisabeth Ralfkiaer
Journal:  APMIS       Date:  2013-09-06       Impact factor: 3.205

4.  MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma.

Authors:  Veronica Monsálvez; Santiago Montes-Moreno; María J Artiga; Maria E Rodríguez; Beatriz S Espiridión; Maria Lozano; Ricardo Fernández-de-Misa; Jose L Rodríguez-Peralto; Miguel A Piris; Pablo L Ortíz-Romero
Journal:  Mod Pathol       Date:  2013-04       Impact factor: 7.842

5.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.

Authors:  John A Pulikkan; Viola Dengler; Philomina S Peramangalam; Abdul A Peer Zada; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

6.  MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.

Authors:  Leslie van der Fits; Marloes S van Kester; Yongjun Qin; Jacoba J Out-Luiting; Fiona Smit; Willem H Zoutman; Rein Willemze; Cornelis P Tensen; Maarten H Vermeer
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

7.  STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Authors:  Katharina L Kopp; Ulrik Ralfkiaer; Lise Mette R Gjerdrum; Rikke Helvad; Ida H Pedersen; Thomas Litman; Lars Jønson; Peter H Hagedorn; Thorbjørn Krejsgaard; Robert Gniadecki; Charlotte M Bonefeld; Lone Skov; Carsten Geisler; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

Review 8.  Recent advances in cutaneous lymphomas.

Authors:  Reinhard Dummer; Kenji Asagoe; Antonio Cozzio; Günter Burg; Udo Doebbeling; Philippa Golling; Kazuyasu Fujii; Mirjana Urosevic
Journal:  J Dermatol Sci       Date:  2007-10-25       Impact factor: 4.563

9.  Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus.

Authors:  P Kanavaros; D Ioannidou; M Tzardi; G Datseris; J Katsantonis; G Delidis; A Tosca
Journal:  Pathol Res Pract       Date:  1994-09       Impact factor: 3.250

10.  Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.

Authors:  Min Li; Xiang Zhang; Wen-jing Zhou; Yue-hua Chen; Hui Liu; Lin Liu; Chun-mei Yang; Wen-bin Qan
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

View more
  35 in total

Review 1.  microRNA deregulation in keloids: an opportunity for clinical intervention?

Authors:  Xin Yu; Zheng Li; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-10-21       Impact factor: 6.831

Review 2.  Circulating epigenetic biomarkers in melanoma.

Authors:  Yu Xin; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-11

Review 3.  New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphoma.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

4.  MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.

Authors:  Bin Chen; Wenyan Pan; Xiaoxi Lin; Zhenzhen Hu; Yunbo Jin; Hui Chen; Gang Ma; Yajing Qiu; Lei Chang; Chen Hua; Yun Zou; Yang Gao; Hanru Ying; Dongze Lv
Journal:  Tumour Biol       Date:  2015-09-26

5.  miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.

Authors:  Shuguang Zhou; Bing Wang; Jun Hu; Yucheng Zhou; Mengzhen Jiang; Mingyu Wu; Liming Qin; Xuming Yang
Journal:  Tumour Biol       Date:  2016-01-13

6.  MicroRNA-765 regulates neural stem cell proliferation and differentiation by modulating Hes1 expression.

Authors:  Siou Li; Weina Zhao; Qing Xu; Yang Yu; Changhao Yin
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 7.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

8.  [Expression and significance of microRNA-125b in tongue squamous cell carcinoma].

Authors:  Jian Wang; Guang-Peng Yan; Chao Guo; Jun Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-02-01

Review 9.  Epigenetic deregulations in chordoma.

Authors:  Xin Yu; Zheng Li
Journal:  Cell Prolif       Date:  2015-08-10       Impact factor: 6.831

Review 10.  Role of microRNAs in primary central nervous system lymphomas.

Authors:  Xin Yu; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-03-16       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.